Researchers from Brigham and Women’s Hospital (Boston,MA,USA;www.brighamandwomens.org) have designed a tiny device, no larger than a grain of rice, that is capable of conducting multiple experiments concurrently to assess the impact of novel treatments on hardest-to-treat brain cancers.

This innovative device designed for testing glioma treatments can be integrated seamlessly into standard surgical procedures and offers unprecedented insights into drug effects on glioma tumors.

The device did not cause any adverse reactions in a phase 1 clinical trial, confirming its safety and seamless integration into surgical practice.